Ulrikka Klarskov Kjær
Executive Officer
Diabetes and Endocrinology
PILA PHARMA
Sweden
Biography
Ulrikka Klarskov Kjær (Danish, born 1963) joined the Board of Directors in PILA PHARMA in late 2017 due to her unique competences within health economics and sustainable global development. Ulrikka Klarskov Kjær provides significant experience to PILA PHARMA within health economics, optimisation of drug development processes (cost, time, quality), global health care reforms, and sustainable global development. These competencies are important for PILA PHARMA in order to evaluate the economic value of the health benefits of our current development candidate.
Research Interest
Ulrikka’s key competencies are: Health economic evaluation, business process development, project management of high complexity projects, and programmes in large organisations. Furthermore, she has extensive experience within the health care systems and socio-economic challenges in developing countries, Africa in particular.
